Finom, an Amsterdam-based challenger bank for SMBs that claims to have doubled its revenue in 2024, closed a €115 million Series C equity round (around $133 million).
What happens when a Silicon Valley entrepreneur, a synthetic biology expert, and a world-renowned cancer researcher team up? They create Earli—a startup rewriting the rules of cancer detection and treatment.
Does it really matter how diversified your portfolio is if you can’t handle your emotions when the market starts crashing and your assets are losing value?